Back to results
US 9,789,132 B2Granted
Methods targeting miR-128 for regulating cholesterol/lipid metabolism
AssigneeThe General Hospital Corporation
InventorsAnders M. Naar, Seyed Hani Najafi-Shoushtari
Life of this patent
Estimating the term…
Abstract
Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.
Claims15
A method of reducing levels of serum LDL, reducing levels of serum triglycerides, and/or increasing levels of serum HDL in a subject, the method comprising administering to the subject a therapeutically effective amount of an inhibitory nucleic acid that is complementary to all or part of any of SEQ ID NOs:
- 1-6, thereby reducing levels of serum LDL, reducing levels of serum triglycerides, and/or increasing levels of serum HDL in the subject.
Dependencies are inferred from the claim text.